- Home
- KRNY vs ESPR Comparison
KRNY vs ESPR Comparison
Compare KRNY & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRNY
- ESPR
- Stock Information
- Founded
- KRNY 1884
- ESPR 2008
- Country
- KRNY United States
- ESPR United States
- Employees
- KRNY N/A
- ESPR N/A
- Industry
- KRNY Savings Institutions
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- KRNY Finance
- ESPR Health Care
- Exchange
- KRNY Nasdaq
- ESPR Nasdaq
- Market Cap
- KRNY 420.7M
- ESPR 445.6M
- IPO Year
- KRNY 2005
- ESPR 2013
- Fundamental
- Price
- KRNY $6.74
- ESPR $2.75
- Analyst Decision
- KRNY Buy
- ESPR Buy
- Analyst Count
- KRNY 2
- ESPR 6
- Target Price
- KRNY $7.75
- ESPR $6.50
- AVG Volume (30 Days)
- KRNY 376.6K
- ESPR 6.2M
- Earning Date
- KRNY 10-23-2025
- ESPR 11-06-2025
- Dividend Yield
- KRNY 6.54%
- ESPR N/A
- EPS Growth
- KRNY N/A
- ESPR N/A
- EPS
- KRNY 0.42
- ESPR N/A
- Revenue
- KRNY $151,629,000.00
- ESPR $268,125,000.00
- Revenue This Year
- KRNY $14.22
- ESPR $9.87
- Revenue Next Year
- KRNY N/A
- ESPR N/A
- P/E Ratio
- KRNY $16.13
- ESPR N/A
- Revenue Growth
- KRNY 12.84
- ESPR N/A
- 52 Week Low
- KRNY $5.45
- ESPR $0.69
- 52 Week High
- KRNY $8.59
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- KRNY 61.66
- ESPR 71.39
- Support Level
- KRNY $6.35
- ESPR $2.37
- Resistance Level
- KRNY $6.72
- ESPR $2.85
- Average True Range (ATR)
- KRNY 0.18
- ESPR 0.18
- MACD
- KRNY -0.01
- ESPR -0.00
- Stochastic Oscillator
- KRNY 73.58
- ESPR 81.48
About KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.